1 Background Congenital heart disease(CHD)is the most common major congenital anomaly,affecting approximately one in every 100 live births[1].Among congenital anomalies,66%of preventable deaths are due to CHD,and 58%o...1 Background Congenital heart disease(CHD)is the most common major congenital anomaly,affecting approximately one in every 100 live births[1].Among congenital anomalies,66%of preventable deaths are due to CHD,and 58%of the avertable morbidity and mortality due to congenital anomalies would result from scaling congenital heart surgery services[2].Every year,nearly 300,000 children and adults die from CHD,the majority of whom live in low-and middle-income countries(LMICs)[3].Approximately 49%of all individuals with CHD will require surgical or interventional care at some point in their lifetime[4];as a result of advances in access to and the delivery of such services,over 95%of children born with CHD in high-income countries now live into adulthood[3].Here,adults have surpassed children in the number of CHD cases at a ratio of 2:1[5].展开更多
Objective To investigate the clinical outcomes of children with congenital heart disease （CHD） requiring extracorporeal membrane oxygenation （ECMO） and left ventricular assist device （LVAD） support after cardiac...Objective To investigate the clinical outcomes of children with congenital heart disease （CHD） requiring extracorporeal membrane oxygenation （ECMO） and left ventricular assist device （LVAD） support after cardiac surgery. Methods A total of 22 patients with CHD who required postcardiotomy mechanical circulatory support between March 2004 and March 2011 （85 months ） were analyzed retrospectively. Median age of the patients was 420 d （ 15 d - 4 years） and median weight was 3.4 kg （ 2 - 14. 5 kg ）. Eight patients were put on ECMO, while 14 patients were placed on LVAD. Results Thirteen （59%） patients died and 9 （41% ） survived to discharge. In survivals, the duration of LVAD and the duration of ECMO were both shorter than those of nonsurvivals （P 〈 O. 05）. The main complication was bleeding. Conclusion The earlier treatment and application of more advanced cardiac support devices for CHD patients are key factors for reducing complications.展开更多
文摘1 Background Congenital heart disease(CHD)is the most common major congenital anomaly,affecting approximately one in every 100 live births[1].Among congenital anomalies,66%of preventable deaths are due to CHD,and 58%of the avertable morbidity and mortality due to congenital anomalies would result from scaling congenital heart surgery services[2].Every year,nearly 300,000 children and adults die from CHD,the majority of whom live in low-and middle-income countries(LMICs)[3].Approximately 49%of all individuals with CHD will require surgical or interventional care at some point in their lifetime[4];as a result of advances in access to and the delivery of such services,over 95%of children born with CHD in high-income countries now live into adulthood[3].Here,adults have surpassed children in the number of CHD cases at a ratio of 2:1[5].
文摘Objective To investigate the clinical outcomes of children with congenital heart disease （CHD） requiring extracorporeal membrane oxygenation （ECMO） and left ventricular assist device （LVAD） support after cardiac surgery. Methods A total of 22 patients with CHD who required postcardiotomy mechanical circulatory support between March 2004 and March 2011 （85 months ） were analyzed retrospectively. Median age of the patients was 420 d （ 15 d - 4 years） and median weight was 3.4 kg （ 2 - 14. 5 kg ）. Eight patients were put on ECMO, while 14 patients were placed on LVAD. Results Thirteen （59%） patients died and 9 （41% ） survived to discharge. In survivals, the duration of LVAD and the duration of ECMO were both shorter than those of nonsurvivals （P 〈 O. 05）. The main complication was bleeding. Conclusion The earlier treatment and application of more advanced cardiac support devices for CHD patients are key factors for reducing complications.
